Galapagos NV (GLPG)

Last Price:  

Company Description

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $1.00B
Net Income (Most Recent Fiscal Year) $167.83M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) 38.45
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 12.23
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 4.14
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 32.06
Pre-Tax Margin (Trailing 12 Months) 15.70%
Net Margin (Trailing 12 Months) 15.42%
Return on Equity (Trailing 12 Months) 12.45%
Return on Assets (Trailing 12 Months) 6.07%
Current Ratio (Most Recent Fiscal Quarter) 9.28
Quick Ratio (Most Recent Fiscal Quarter) 9.28
Debt to Common Equity (Most Recent Fiscal Quarter) 0.01
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $58.75
Earnings per Share (Most Recent Fiscal Quarter) $-0.86
Earnings per Share (Most Recent Fiscal Year) $5.46
Diluted Earnings per Share (Trailing 12 Months) $2.54
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 65.25M
Free Float 63.35M
Market Capitalization $13.07B
Average Volume (Last 20 Days) 0.10M
Beta (Past 60 Months) 1.19
Percentage Held By Insiders (Latest Annual Proxy Report) 2.91%
Percentage Held By Institutions (Latest 13F Reports) 11.71%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%